BioMarin Pharmaceutical Inc - Company Profile
Powered by 
All the data and insights you need on BioMarin Pharmaceutical Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date BioMarin Pharmaceutical Inc Strategy Report
- Understand BioMarin Pharmaceutical Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on BioMarin Pharmaceutical Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 09 Feb 2022 | BioMarin Pharma to Sell Rare Pediatric Disease Priority Review Voucher (PRV) | Asset Transaction | - |
BioMarin Pharmaceutical Inc |
| 16 Dec 2021 | BioMarin Pharma Enters into Co-Development Agreement with Skyline Therapeutics (Geneception Therapeutics) | Partnership | - |
Geneception Therapeutics
BioMarin Pharmaceutical Inc |
| 15 Nov 2021 | Entos Pharma and BioMarin Pharma Enter into Agreement | Partnership | - |
BioMarin Pharmaceutical Inc
Entos Pharmaceuticals Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer